November 5, 2008. San Diego --
Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing
and sales of products for the diagnosis and treatment of coronary and
peripheral artery disease,will report its operating results for the
third quarter and first nine months of fiscal 2008 on Wednesday, November
5.
The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m. Eastern Standard Time), Wednesday, November 5, hosted by Scott Huennekens, president and chief executive officer, and John Dahldorf, chief financial officer.
The teleconference can be accessed by calling (719) 325-4761, passcode 8632414. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available through the company's website at http://www.volcanocorp.com.
A replay of the conference call will be available through Wednesday, November 12, at (719) 457-0820, passcode 8632414, and via the company's website.
About Volcano Corporation
Volcano Corporation (NASDAQ: VOLC) offers a broad suite of devices designed to
facilitate endovascular procedures, enhance the diagnosis of vascular and structural
heart disease and guide optimal therapies. The company's intravascular ultrasound
(IVUS) product line includes ultrasound consoles that can be integrated directly
into virtually any modern cath lab. Volcano IVUS offers unique features, including
both single-use phased array and rotational IVUS imaging catheters, and advanced
functionality options, such as VH™ tissue characterization and ChromaFlo®.
Volcano also provides functional measurement (FM) consoles and single-use pressure
and flow guide wires and is developing a line of ultra-high resolution Optical
Coherence Tomography (OCT) systems and catheters. Currently, more than 3,500
Volcano IVUS and FM systems are installed worldwide, with approximately half
of its revenues coming from outside the United States. For more information,
visit the company's website at http://www.volcanocorp.com.
(Disclaimer: external
links to news, press releases and other timely information
sources are provided as a service by Angioplasty.Org, which
is not responsible for the content found on any external
sites. Items marked with a ($$) indicate that the external
site normally restricts viewing to paid subscribers. Other
sites may require free registration.
